|
|
||||||||
CUTTING EDGE |

* Department of Molecular Virology, Immunology, and Medical Genetics and
Department of Microbiology, The Ohio State University, Columbus, OH 43210
Macrophage migration inhibitory factor (MIF) has been implicated in the pathogenesis of inflammatory and autoimmune diseases. The role of MIF in the progression of experimental autoimmune encephalomyelitis (EAE) was explored using MIF/ mice. Wild-type mice showed a progressive disease course, whereas MIF/ mice exhibited acute signs but no further progression of clinical disease. MIF/ mice displayed markedly elevated corticosterone levels and significant decreases in the inflammatory cytokines TNF-
, IFN-
, IL-2, and IL-6 before, during, and after EAE onset. Taken together, these findings support that MIF is an important mediator of EAE progression through glucocorticoid antagonism and up-regulation of the inflammatory response.
Related articles in The JI:
This article has been cited by other articles:
![]() |
C. A. Learn, P. E. Fecci, R. J. Schmittling, W. Xie, I. Karikari, D. A. Mitchell, G. E. Archer, Z. Wei, H. Dressman, and J. H. Sampson Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T Cells in Patients with Malignant Glioma Reveals Differential Expression of the Immunologic Transcriptome Compared with T Cells from Healthy Volunteers Clin. Cancer Res., December 15, 2006; 12(24): 7306 - 7315. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |